Immunology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Immunology Case Reports (2023) Volume 6, Issue 2

Role of macrophages in the development of psoriasis.

Roman Campbell*

Department of Immunology, Benaroya Research Institute, United States

*Corresponding Author:
Roman Campbell
Department of Immunology
Benaroya Research Institute
United States
E-mail:Roman@benaroyaresearch.org

Received:30-Mar-2023, Manuscript No. AAICR-23-97432; Editor assigned:03-Apr-2023, PreQC No. AAICR-23-97432(PQ); Reviewed:17-Apr-2023, QC No. AAICR-23-97432; Revised:21-Apr-2023, Manuscript No. AAICR-23-97432(R); Published:28-Apr-2023, DOI:10.35841/aaicr-6.2.144

Citation: Campbell R. Role of macrophages in the development of psoriasis. Immunol Case Rep. 2023;6(2):144

Visit for more related articles at Immunology Case Reports

Introduction

Psoriasis is a chronic autoimmune skin condition characterized by the rapid growth of skin cells resulting in red, scaly, and itchy patches. The exact cause of psoriasis is not fully understood, but it is believed to be a result of an overactive immune system attacking healthy skin cells. One of the key players in the development and progression of psoriasis are macrophages. Macrophages are a type of white blood cell that plays a vital role in the immune system's response to pathogens and tissue damage. They are found in almost all tissues of the body and are known for their ability to engulf and digest foreign substances and damaged cells. In the context of psoriasis, macrophages are thought to be involved in the inflammatory response that triggers the disease [1].

Studies have shown that macrophages play a crucial role in the development of psoriasis. In psoriatic skin, macrophages accumulate in large numbers and release cytokines, which are signaling molecules that trigger inflammation. One of the key cytokines involved in psoriasis is tumor necrosis factor-alpha (TNF-α), which is produced by macrophages and other immune cells. TNF-α is known to promote the growth and differentiation of skin cells, which contributes to the thickening and scaling of psoriatic lesions. Another cytokine produced by macrophages in psoriasis is interleukin-23 (IL-23). IL-23 is a key driver of the inflammatory response in psoriasis and is required for the differentiation and activation of a type of immune cell called Th17 cells. Th17 cells, in turn, produce other cytokines that further amplify the inflammatory response in psoriasis [2].

In addition to producing cytokines, macrophages in psoriasis also contribute to the development of the disease by promoting angiogenesis, or the growth of new blood vessels. This is important because psoriatic lesions require a steady supply of nutrients and oxygen to grow and thrive. By promoting angiogenesis, macrophages help to sustain the growth and proliferation of psoriatic lesions. Macrophages play a crucial role in mediating psoriasis. They produce cytokines that trigger inflammation, promote the growth and differentiation of skin cells, and contribute to angiogenesis. Understanding the role of macrophages in psoriasis could lead to the development of new treatments that target these cells and reduce the severity of the disease [3].

Macrophages are not only involved in the initial onset of psoriasis but also in its chronicity. Chronic inflammation is a hallmark of psoriasis, and macrophages play a significant role in sustaining it. In psoriatic lesions, macrophages can differentiate into a subtype called M1 macrophages, which have pro-inflammatory properties and contribute to the chronic inflammation seen in psoriasis. M1 macrophages produce cytokines such as IL-1β, IL-6, and IL-12, which amplify the inflammatory response and promote the survival of other inflammatory cells. On the other hand, macrophages can also differentiate into a subtype called M2 macrophages, which have anti-inflammatory properties and are involved in tissue repair and remodeling. In psoriasis, M2 macrophages are less abundant than M1 macrophages, indicating a shift in the macrophage polarization towards pro-inflammatory M1 macrophages. This polarization shift can be influenced by various factors, such as cytokines, environmental cues, and genetic factors [4].

Besides, macrophages can also interact with other immune cells involved in psoriasis. For example, macrophages can interact with dendritic cells, another immune cell that presents antigens to T cells, triggering an immune response. Dendritic cells can activate macrophages through various signaling pathways, leading to the production of cytokines and the promotion of inflammation. In recent years, the role of macrophages in psoriasis has gained more attention, and researchers are exploring ways to target macrophages as a potential therapeutic strategy. One approach is to use drugs that target the cytokines produced by macrophages, such as TNF-α inhibitors or IL-23 inhibitors. Another approach is to modulate the polarization of macrophages towards an anti-inflammatory phenotype, which can be achieved through the use of certain compounds or environmental cues [5].

Macrophages play a complex role in mediating psoriasis, ranging from triggering the initial inflammatory response to sustaining chronic inflammation. A better understanding of the mechanisms underlying macrophage involvement in psoriasis could lead to the development of novel therapies that target macrophages and reduce the severity of the disease.

Conclusion

Psoriasis is a complex autoimmune disease with a wide range of cellular and molecular processes involved in its development and progression. Macrophages, as one of the key players in the immune system, have been shown to play a crucial role in mediating psoriasis. They produce cytokines that trigger inflammation, promote the growth and differentiation of skin cells, and contribute to angiogenesis. Moreover, macrophages sustain chronic inflammation in psoriasis by polarization towards pro-inflammatory M1 phenotype.

References

  1. Wang H, Peters T, Kess D, et al. Activated macrophages are essential in a murine model for T cell–mediated chronic psoriasiform skin inflammation. J Clin Invest. 2006;116(8):2105-14.

    2. Indexed at, Google Scholar,Cross Ref

  2. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med. 2005;202(1):135-43.

    3. Indexed at, Google Scholar, Cross Ref

  3. Nestle FO, Turka LA, Nickoloff B. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest. 1994;94(1):202-9.

    4. Indexed at, Google Scholar, Cross Ref

  4. Nickoloff BJ, Wrone-Smith T. . Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 1999;155(1):145-58.

    5. Indexed at, Google Scholar, Cross Ref

  5. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, et al. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc Natl Acad Sci. 1996;93(5):2116-21.

    6. Indexed at, Google Scholar, Cross Ref

Get the App